October 18, 2016 / 1:31 PM / 10 months ago

BRIEF-PExA receives Horizon 2020 funding

Oct 18 (Reuters) - PExA AB :

* The European Commission has selected PExAs project "BREATH: Biomarkers for Respiratory diseases detected in Exhaled Air through a new Technological instrument for research and Healthcare markets" for funding through the Research and Innovation Framework Program Horizon 2020

* Each project receives 50,000 euros ($54,940.00) to carry out a feasibility study and to prepare a Phase 2 program which, if granted, could result in significant additional funding

* A Phase 2 program, could be financed up to 2.5 million euros by the European Commission

* The feasibility study is expected to be completed during H1 2017 Source text: bit.ly/2eBpBjA

Further company coverage:

$1 = 0.9101 euros Gdynia Newsroom

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below